JAKARTA - PT Nanotech Indonesia Global Tbk (NANO) has entered a strategic transformation phase after obtaining funding support of IDR 200 billion from SoftBank.
The funds are prepared as a standby fund to support the implementation of the company's strategic projects on an ongoing basis.
This step was followed by strengthening governance through the involvement of Himawan Sutanto as the President Commissioner of SoftBank Ventura Indonesia.
The presence of experienced figures is considered to strengthen the credibility and synergy between global capital and national technology development.
In terms of partnerships, LDA Capital is finalizing the formation of the LDA Investment Board at the company level as part of strengthening investment supervision and accelerating the commercialization of innovation, especially in the health technology sector.
Fundamentally, NANO together with the Nano Center Indonesia owns 85 technology patents that are ready to be marketed.
The implementation of this technology has entered the commercial stage through collaboration with health service institutions such as Mandaya Royal Hospital.
NANO President Director, Suryandaru, said that the transformation of the company's business began in early 2026 with a long-term growth orientation and value creation.
The plan to distribute dividends for the 2025 fiscal year reflects management's optimism about the company's performance and cash flow going forward.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
